Company research / AKBA
Akebia Therapeutics, Inc. (AKBA)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Akebia Therapeutics, Inc. reported revenue of $236.20M. Revenue grew 47.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $219.06M.
Key ratios (year ended 2025-12-31)
83.3%
Gross margin (computed)
9.9%
Operating margin
-2.3%
Net margin
-16.4%
Return on year-end equity
47.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.